Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 114 results for "lacosamide"

Human medicines European public assessment report (EPAR): Vi...

This is a summary of the European public assessment report (EPAR) for Vimpat. It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and ... European Medicines Agency, 1 month ago

New real-life and clinical data presented on VIMPAT® (lacosamide) at the 11th ECE

Brussels (Belgium), Monday 30th June, 2014 - 0700 (CEST) - UCB today announced data from two studies evaluating the efficacy and safety of VIMPAT® (lacosamide) as early adjunctive treatment in adults with partial-onset seizures. The results are ...
 Noodls4 weeks ago Multiple data presentations at leading European epilepsy congress highlight UCB's commitment to advancing epilepsy research  Noodls1 month ago UCB announces encouraging data from two partial-onset seizure studies  Individual.com3 weeks ago

Total Synthesis of Lacosamide

Total synthesis of anticonvulsant amino acid, lacosamide, is reported. The key step is stereospecific allyl cyanate-to-isocyanate rearrangement, which proceeds with chirality transfer. The enantiopure starting material for the rearrangement step was ...
 Journal of Organic Chemistry1 month ago

Court Report - July 2014 #3

About Court Report: Each week we will report briefly on recently filed biotech and pharma cases . GlaxoSmithKline LLC et al. v. Glenmark Generics Inc. USA 1:14-cv-00877; filed July 3, 2014 in the District Court of Delaware • ...
 JD Supra1 day ago Seizures - Pipeline Review, H1 2014  Franklin Credit Management Corporation4 weeks ago
[x]  

Global Epilepsy Therapeutics Market: Industry Analysis, Size, Share, Growth and Forecast 2019

Epilepsy is a group of long-term neurological disorders that is characterized by recurring seizures. These seizures are episodes that occur when group of nerve cells or neurons in brain sends wrong signals. Seizures could differ from primary ...
 Wall Street Select1 week ago Asia Epilepsy Therapeutics Market to rise slightly from $1.1bn in 2012 to $1.5bn in 2019  TransWorldNews4 weeks ago
[x]  

Quest Diagnostics Investments Assigned Patent

By Targeted News Service ALEXANDRIA, Va., July 17 -- Quest Diagnostics Investments, Wilmington, Delaware, has been assigned a patent (8,779,355) developed by four co-inventors for "methods for detecting lacosamide by
 Financial Content1 week ago

Epilepsy Therapeutics in Asia Pacific Markets to 2019 - Treatment Options Enhanced As Novel Next Generation AEDs Show Improved Safety and Tolerability

/PRNewswire/ -- Reportbuyer.com has added a new market research report: Summary GBI Research, the leading business intelligence provider, has released its latest research, " ", which provides in-depth analysis of epilepsy market within the ...
 MoneyShow.com1 week ago Epilepsy Therapeutics in Major Developed Markets to 2019 - New AEDs with Novel Mechanisms of Action Signal a Shift in Treatment Patterns  TVNewsCheck2 weeks ago
[x]  
JPMA

Diabetic Neuropathy: Part 2

Introduction Diabetic neuropathy (DN) is a major cause of disability and reduced quality of life. In the previous review we discussed the prevalence, classification, clinical features, pathophysiology and recent advances in the diagnosis of ...
 JPMA1 month ago

Barrow Neurological Institute

InVivo Therapeutics Corporation(NVIV) Announces As Third Clinical Trial Site For Neuro-Spinal Scaffold 6/26/2014 8:53:34 AM More... New Vision of How We Explore Our World, Barrow Neurological Institute Study 4/5/2013 11:45:31 AM More... ...
 ClinicSpace1 month ago

"Use of the Phytocannabinoid Cannabidiol (Cbd) in Combination with a Standard Anti-Epileptic Drug (Saed) in the Treatment of Epilepsy" in Patent...

"Use of the Phytocannabinoid Cannabidiol (Cbd) in Combination with a Standard Anti-Epileptic Drug (Saed) in the Treatment of Epilepsy" in Patent Application Approval Process By a News Reporter-Staff News Editor at Pharma Business Week -- A patent ...
 4 Traders1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less